Understanding Pathways for Successful Clinical Drug Trials

Clinical trials are the indispensable final stage in drug development, ensuring new therapies are safe and effective before reaching patients. These trials are highly regulated, immensely complex, and involve multiple phases, significant investment, and rigorous ethical oversight. This paper, published in Methods and Findings in Experimental and Clinical Pharmacology in 2009, likely serves as a comprehensive overview or a foundational guide to the intricate landscape of clinical research. The specific knowledge gap this study addresses is demystifying the intricate processes, critical decision points, and regulatory 'gateways' involved in navigating the journey from preclinical research to market approval for novel pharmaceutical agents, providing a roadmap for stakeholders.